ITOCO Inc.
TORONTO, ON / ACCESSWIRE / October 27, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to release information about the Nopal Cactus' ability to act as a key component to land reclamation in addition to its significant carbon reducing properties.
Desertification or land degradation is occurring worldwide and directly affects millions of people, especially the poor. Nopal Cactus is already widely cultivated in arid regions worldwide as a standalone crop because of its ability to grow and thrive in hard and dry conditions.
Importantly, their root characteristics allow them to prevent or avoid wind and rain erosion. When the Nopal Cactus is present, other plants and trees can take hold in poor growing environments more easily.
ITOCO's Nopal Cactus Carbon Credit program is designed to achieve significant land rehabilitation and reclamation by planting in association with less robust trees and crops. In Mexico, the Nopal Cactus has demonstrated an ability to turn dry desert into savannah like conditions relatively quickly and economically by leveraging it's unique properties.
Therefore, establishment of production systems based on cactus can bring food self-sufficiency in desert and arid areas, and well as reclaiming ‘wasted' land.
The Nopal Cactus is one of the best plants for the reforestation of arid areas as they strongly resist scarce rain and high temperature. Moreover, the Nopal Cactus itself provides food via its leaves and fruit; and can be used as a biofuel, fertilizer, and can be easily processed into an excellent substitute for leather. Cultivation of the Cactus is relatively simple, and the plant grows quickly.
Our ITOCO Nopal Cactus Carbon Capture Program in Mexico has demonstrated Nopal Cactus farming innovations that leverages Nopal Cactus' superb adaptations to dry and arid landscape areas that including fixing carbon dioxide at night and closing the spores (stomata) during the day, thus earning producers carbon credits at an accelerated pace in under twelve months.
ITOCO will be presenting its Nopal Carbon Capture program as an addition to the Great Green Wall project now being implemented in more than 20 countries across Africa. To date, more than eight billion dollars have been mobilized and pledged for its support internationally.
When complete, the Wall will be the largest living structure on the planet - an 8,000 km natural wonder of the world stretching across the entire width of the continent.
We believe that introducing a Nopal Cactus component to the Great Green Wall project would significantly improve the speed and efficacy of the land rehabilitation by allowing other plants to take hold more easily.
The ITOCO Nopal Cactus Program has already been proven with over 1,450 Hectares under management with the support of the Government of Mexico, which has endorsed the Paris Agreement adopted at the twenty-first session of the Conference of the Parties ("COP") to the United Nation Framework Convention on Climate Change ("UNDCC") and is taking action to mitigate its Green House Gas ("GHG') emissions in accordance with the Land Use Protocol of the United Nations (LULUCF), by 2030.
About ITOCO Inc.:
ITOCO's mission is to be a global leader in developing, distributing, and producing Bio Tech related technologies and methodologies in a compliant environmentally friendly manner. ITOCO Inc. trades on the OTC Markets, symbol: ITMC. ITOCO is a 14-year-old publicly quoted specialty Bio Tech development, production and distribution company based in Toronto Canada and Nevada USA. Itoco seeks to partner with outstanding individuals and companies within this field to joint venture, research, and co-develop Bio Tech related products and technologies to the market.
Forward-Looking Statements
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, potential, intends, plans, hopes, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
CONTACT:
Michael Paul, C.E.T.
President & CEO
ITOCO INC
ir@itoco.net
+1-800-805-1521
www.itoco.net
SOURCE: ITOCO Inc.
View source version on accesswire.com:
https://www.accesswire.com/669803/Itoco-Provides-Information-About-the-Nopal-Cactus-Ability-To-Act-as-a-Key-Component-in-Land-Reclamation-in-Addition-to-Its-Significant-Carbon-Reducing-Properties
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
